List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 132 studies with search of: biliary tract disease | Open Studies
Include studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Recruiting Effect of a Fatty Meal on Endoscopic Retrograde Cholangiopancreatography (ERCP)
Condition: Biliary Tract Disease
Intervention: Behavioral: a fatty meal
2 Recruiting Evaluation of Surgical Risk in Elderly Patients Submitted to Elective Surgery
Conditions: Peripheral Vascular Diseases;   Digestive Diseases;   Biliary Tract Diseases
Intervention: Procedure: SURGERY
3 Not yet recruiting A Randomised Phase II/III Study of Cediranib (AZD2171) or Placebo in Combination With Cisplatin/Gemcitabine for Patients With Advanced Biliary Tract Cancers
Condition: Biliary Tract Neoplasms
Interventions: Drug: gemcitabine;   Drug: cisplatin;   Drug: Placebo;   Drug: cediranib
4 Recruiting Vandetanib Gemcitabine Or Placebo Plus Gemcitabine Or Vandetanib Monotherapy In Advanced Biliary Tract Cancer
Conditions: Biliary Tract Cancer;   Gallbladder Cancer;   Cancer Of The Extrahepatic Bile Duct;   Ampullary Carcinoma
Interventions: Drug: ZD6474, VANDETANIB;   Drug: GEMCITABINE;   Drug: Placebo matching ZD6474
5 Recruiting A Study of FOLFOX6 With Bevacizumab for Biliary System Carcinoma
Condition: Biliary Tract Cancer
Intervention: Drug: Modified FOLFOX6 and Bevacizumab
6 Recruiting Gemcitabine and Capecitabine to Treat Patients With Advanced Pancreatic and Biliary Cancers
Conditions: Pancreatic Cancer;   Biliary Cancer
Interventions: Drug: gemcitabine;   Drug: capecitabine
7 Recruiting Gemcitabine and Cetuximab in Patients With Advanced or Metastatic Biliary Tract Cancer: A Multicenter Phase II Study
Condition: Time to Progression
Intervention: Drug: gemcitabine + cetuximab
8 Recruiting Cyberknife Radiosurgery Boost for Hilar Cholangiocarcinoma (Klatskin Tumor)
Conditions: Cholangiocarcinoma;   Klatskin Tumor;   Biliary Tract Cancer
Intervention: Radiation: External beam radiation and Cyberknife radiosurgery boost and capecitabine
9 Recruiting A Study of Combination of Gemcitabine, Oxaliplatin (GEMOX)-Sorafenib in Patients With Advanced Biliary Tract Cancer
Conditions: Cholangiocarcinoma;   Biliary Tract Cancer;   Gallbladder Cancer
Interventions: Drug: Gemcitabine;   Drug: Oxaliplatin;   Drug: Sorafenib
10 Recruiting Fluorouracil, Cisplatin, and Radiation Therapy or Gemcitabine and Oxaliplatin in Treating Patients With Nonmetastatic Biliary Tract Cancer That Cannot Be Removed By Surgery
Conditions: Extrahepatic Bile Duct Cancer;   Gallbladder Cancer;   Liver Cancer
Interventions: Drug: cisplatin;   Drug: fluorouracil;   Drug: gemcitabine hydrochloride;   Drug: oxaliplatin
11 Recruiting Biliary Stenting With or Without Photodynamic Therapy in Treating Patients With Locally Advanced, Recurrent, or Metastatic Cholangiocarcinoma or Other Biliary Tract Tumors That Cannot Be Removed by Surgery
Conditions: Extrahepatic Bile Duct Cancer;   Gallbladder Cancer
Interventions: Drug: porfimer sodium;   Procedure: biliary stenting
12 Recruiting Capecitabine or Observation After Surgery in Treating Patients With Biliary Tract Cancer
Conditions: Extrahepatic Bile Duct Cancer;   Gallbladder Cancer;   Liver Cancer
Interventions: Drug: capecitabine;   Other: clinical observation;   Procedure: adjuvant therapy
13 Recruiting Gemcitabine Hydrochloride, Oxaliplatin, and Erlotinib Hydrochloride in Treating Patients With Advanced Biliary Tract Cancer, Pancreatic Cancer, Duodenal Cancer, or Ampullary Cancer
Conditions: Extrahepatic Bile Duct Cancer;   Gallbladder Cancer;   Liver Cancer;   Pancreatic Cancer;   Periampullary Adenocarcinoma;   Small Intestine Cancer
Interventions: Drug: erlotinib hydrochloride;   Drug: gemcitabine hydrochloride;   Drug: oxaliplatin;   Other: laboratory biomarker analysis
14 Recruiting Gemcitabine With or Without Cisplatin in Treating Patients With Unresectable Locally Advanced or Metastatic Cholangiocarcinoma or Other Biliary Tract Tumors
Conditions: Extrahepatic Bile Duct Cancer;   Gallbladder Cancer
Interventions: Drug: cisplatin;   Drug: gemcitabine hydrochloride
15 Recruiting Randomized Study of Tauroursodeoxycholic Acid in Prophylactic Therapy of Total Parenteral Nutrition Associated Cholestasis in Infants
Condition: Cholestasis
Intervention: Drug: tauroursodeoxycholic acid
16 Recruiting Gemcitabine and Cisplatin Plus Sorafenib in Patients With Advanced Biliary Tract Carcinomas Naive to Systemic Therapy
Conditions: Extrahepatic Bile Duct Cancer;   Gallbladder Cancer
Intervention: Drug: Gemcitabine and Cisplatin plus Sorafenib
17 Recruiting Evaluating Predictors & Interventions in Sphincter of Oddi Dysfunction
Condition: Sphincter of Oddi Dysfunction
Interventions: Procedure: Pancreatic Sphincterotomy;   Procedure: Pancreatic and Biliary Sphincterotomy;   Procedure: ERCP
18 Recruiting CO07204-Phase I/II of Oxaliplatin, Capecitabine & Sorafenib for Advanced Pancreatic & Biliary Carcinoma
Conditions: Pancreatic Neoplasms;   Bile Duct Neoplasms
Interventions: Drug: Oxaliplatin;   Drug: Capecitabine;   Drug: Sorafenib
19 Recruiting SILS Cholecystectomy: Cholangiography of the Biliary Tract
Condition: Cholecystolithiasis
Intervention: Procedure: SILS cholangiography
20 Recruiting Irinotecan, Gemcitabine, Chemotherapy for Biliary Tract Cancer
Condition: Biliary Tract Cancer
Intervention: Drug: Irinotecan and Gemcitabine

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services